Viewing Study NCT03637868


Ignite Creation Date: 2025-12-24 @ 5:29 PM
Ignite Modification Date: 2026-01-14 @ 12:07 PM
Study NCT ID: NCT03637868
Status: WITHDRAWN
Last Update Posted: 2020-05-06
First Post: 2018-08-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Eribulin in Brain Metastases From HER2-negative Breast Cancer
Sponsor: Institut Paoli-Calmettes
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module